Monoclonal antibody A5B7-cisplatin conjugate
Alternative Names: Anti-CEA monoclonal antibody A5B7-cisplatin conjugateLatest Information Update: 30 Mar 2007
Price :
$50 *
At a glance
- Originator Biodynamics Research; GlaxoSmithKline; Pharmacia Corporation
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action DNA cross linking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 25 Jan 2001 No-Development-Reported for Cancer in England (Parenteral)
- 23 Jan 2001 Glaxo Wellcome has merged with SmithKline Beecham to form GlaxoSmithKline
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation